The Cost-Effectiveness of Sacubitril/Valsartan for The Treatment of Chronic Heart Failure with Reduced Ejection Fraction in England and Scotland- Applying Real-World Evidence to Enhance Generalisability to A UK Population
Abstract
Authors
D Trueman E Hancock P Jhund JJ McMurray M Petrie C Deschaseaux-Voinet R Haroun ST Alexopoulos V Gielen